PFKFB3
PFKFB3 (6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3) is an enzyme with a significant role in glycolysis regulation in rapidly dividing cells, including in cancer and during development. It is present in a wide variety of tissues and is activated under hypoxic conditions.
PFKFB3 Inhibitors |
|
---|---|
Cat. No. | Product Name / Activity |
5675 | AZ PFKFB3 26 |
Potent and selective PFKFB3 inhibitor | |
5742 | AZ PFKFB3 67 |
Potent and selective PFKFB3 inhibitor | |
Other |
|
Cat. No. | Product Name / Activity |
5121 | 3PO |
PFKFB3 inhibitor | |
5339 | PFK 15 |
Selective PFKFB3 inhibitor |
PFKFB3 (6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3) is an enzyme that plays a key role in the regulation of glycolysis in rapidly dividing cells, so is important in cancer metabolism and during development. PFKFB3 is present in a wide variety of tissues and is induced under hypoxic conditions. The enzyme is one of four PFKFB isozymes and differs from other family members in that it has a very high kinase:phosphatase activity ratio and is overexpressed in a range of cancer types. It is important in the maintenance of fructose-2,6-bisphosphate (F2,6BP) levels in cells, which is an activator of 6-phosphofructo-1-kinase, a rate-limiting enzyme in glycolysis. It has been shown that inhibition of PFKFB3 reduces intracellular F2,6BP levels and suppresses glucose uptake and glycolysis.
PFKFB3 is also a substrate for APC/C (anaphase-promoting complex/cyclosome)-Cdh1, a ubiquitin ligase that controls progression along the cell cycle from G1- to S-phase. The inactivation of APC/C -Cdh1 during mid-to-late G1 results in a rise in PFKFB3 levels and a transient increase in lactate generation. Therefore the presence of PFKFB3 at this particular stage of the cell cycle ensures the upregulation of glycolysis and the provision of sufficient nutrients for cell division.
In addition, F2,6BP activates certain cyclin dependent kinases; in particular, it promotes the Cdk-mediated phosphorylation of p27. p27 has an important role in cell cycle regulation, suppressing transition from G1- to S-phase and promoting apoptosis. Phosphorylation of p27, however, leads to its ubiquitination and proteasomal degradation. So increased F2,6BP levels associated with upregulation of PFKFB3, as seen in cancerous cells, are associated with cell proliferation and inhibition of apoptosis.
External sources of pharmacological information for PFKFB3 :
Literature for PFKFB3
Tocris offers the following scientific literature for PFKFB3 to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Cancer Metabolism Research Product Guide
This product guide reviews some of the main areas in cancer metabolism research and lists around 150 products that can be used to investigate metabolic pathways in cancer including:
- Glycolysis
- Tricarboxylic Acid Cycle
- Lipidogenesis
- 1C Metabolism and Nucleic Acid Synthesis
- Drivers of Metabolic Reprogramming
- pH and Redox Balance
Cell Cycle & DNA Damage Repair Poster
In normal cells, each stage of the cell cycle is tightly regulated, however in cancer cells many genes and proteins that are involved in the regulation of the cell cycle are mutated or over expressed. This poster summarizes the stages of the cell cycle and DNA repair. It also highlights strategies for enhancing replicative stress in cancer cells to force mitotic catastrophe and cell death.
Programmed Cell Death Poster
There are two currently recognized forms of programmed cell death: apoptosis and necroptosis. This poster summarizes the signaling pathways involved in apoptosis, necroptosis and cell survival following death receptor activation, and highlights the influence of the molecular switch, cFLIP, on cell fate.